ZA956033B - Compositions and methods for a bioartificial extracellular matrix - Google Patents
Compositions and methods for a bioartificial extracellular matrixInfo
- Publication number
- ZA956033B ZA956033B ZA956033A ZA956033A ZA956033B ZA 956033 B ZA956033 B ZA 956033B ZA 956033 A ZA956033 A ZA 956033A ZA 956033 A ZA956033 A ZA 956033A ZA 956033 B ZA956033 B ZA 956033B
- Authority
- ZA
- South Africa
- Prior art keywords
- matrix
- peptide fragment
- nerve
- cell adhesive
- adhesive peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/813—Carrier is a saccharide
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/280,646 US5834029A (en) | 1994-07-20 | 1994-07-20 | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA956033B true ZA956033B (en) | 1996-03-11 |
Family
ID=23073997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA956033A ZA956033B (en) | 1994-07-20 | 1995-07-19 | Compositions and methods for a bioartificial extracellular matrix |
Country Status (14)
Country | Link |
---|---|
US (2) | US5834029A (xx) |
EP (1) | EP0772466B1 (xx) |
JP (1) | JPH10503098A (xx) |
KR (1) | KR970704481A (xx) |
AT (1) | ATE255425T1 (xx) |
AU (1) | AU3142395A (xx) |
CA (1) | CA2194493A1 (xx) |
DE (1) | DE69532240D1 (xx) |
FI (1) | FI970218A (xx) |
IL (1) | IL114672A (xx) |
NO (1) | NO970155L (xx) |
TR (2) | TR199500883A2 (xx) |
WO (1) | WO1996002286A1 (xx) |
ZA (1) | ZA956033B (xx) |
Families Citing this family (143)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5834029A (en) * | 1994-07-20 | 1998-11-10 | Cytotherapeutics, Inc. | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment |
US6294202B1 (en) * | 1994-10-06 | 2001-09-25 | Genzyme Corporation | Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers |
US20050152950A1 (en) * | 1995-11-13 | 2005-07-14 | Saffran Bruce N. | Method and apparatus for macromolecular delivery using a coated membrane |
SE9601243D0 (sv) * | 1996-03-29 | 1996-03-29 | Hans Arne Hansson | Promotion of regeneration of organized tissues |
IL118376A0 (en) * | 1996-05-22 | 1996-09-12 | Univ Ben Gurion | Polysaccharide sponges for cell culture and transplantation |
SE9602879D0 (sv) * | 1996-07-26 | 1996-07-26 | Henrich Cheng | Medical device |
US6238429B1 (en) * | 1997-05-05 | 2001-05-29 | Medtronic, Inc. | Biologic cabling |
JP4988076B2 (ja) * | 1997-05-22 | 2012-08-01 | マイヤー,ヤールク | ペプチド被覆インプラントおよびその調製方法 |
AU3097999A (en) * | 1998-03-18 | 1999-10-11 | University Of Pittsburgh | Chitosan-based composite materials containing glycosaminoglycan for cartilage repair |
US6171610B1 (en) | 1998-04-24 | 2001-01-09 | University Of Massachusetts | Guided development and support of hydrogel-cell compositions |
US6027744A (en) * | 1998-04-24 | 2000-02-22 | University Of Massachusetts Medical Center | Guided development and support of hydrogel-cell compositions |
US6593133B1 (en) * | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
US6592623B1 (en) | 1999-08-31 | 2003-07-15 | Virginia Commonwealth University Intellectual Property Foundation | Engineered muscle |
US6903244B1 (en) | 1999-02-26 | 2005-06-07 | University Of Utah Research Foundation | Mice which are +/− or −/− for the elastin gene as models for vascular disease |
US7560275B2 (en) * | 1999-12-30 | 2009-07-14 | Vbi Technologies, L.L.C. | Compositions and methods for generating skin |
US7575921B2 (en) * | 1999-12-30 | 2009-08-18 | Vbi Technologies, L.L.C. | Spore-like cells and uses thereof |
DE20019809U1 (de) * | 2000-05-31 | 2001-07-12 | Fraunhofer Ges Forschung | Knorpelersatz und Biomatrix zur Kultivierung von Zellen |
JP2002078792A (ja) * | 2000-09-07 | 2002-03-19 | Kuraray Co Ltd | 神経再生用材料 |
DE10053611A1 (de) * | 2000-10-28 | 2002-05-02 | Inst Textil & Faserforschung | Bioresorbierbare Nervenleitschiene |
WO2002057428A1 (en) * | 2000-10-30 | 2002-07-25 | University Of Massachusetts | Isolation of spore-like cells from tissues exposed to extreme conditions |
AU2399502A (en) * | 2000-11-14 | 2002-05-27 | R Labs Bvi Nv | Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
US7442370B2 (en) * | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
DE10105040A1 (de) * | 2001-02-05 | 2002-08-14 | Tell Pharm Ag Hergiswil | Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems |
DE10105041A1 (de) * | 2001-02-05 | 2002-08-14 | Tell Pharm Ag Hergiswil | Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten |
US20050192228A1 (en) * | 2001-02-05 | 2005-09-01 | Jean Rapin | Tripeptide derivatives for the treatment of neurodegenerative diseases |
DE10105038B4 (de) * | 2001-02-05 | 2005-07-07 | Neurotell Ag | Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems |
WO2002062961A2 (en) * | 2001-02-06 | 2002-08-15 | Massachusetts Institute Of Technology | Peptide scaffold encapsulation of tissue cells and uses thereof |
US7276580B2 (en) | 2001-03-12 | 2007-10-02 | Biogen Idec Ma Inc. | Neurotrophic factors |
US20040151705A1 (en) * | 2002-03-22 | 2004-08-05 | Shuichi Mizuno | Neo-cartilage constructs and a method for preparation thereof |
JP3871525B2 (ja) * | 2001-04-26 | 2007-01-24 | ニプロ株式会社 | 生体組織または器官再生用器具 |
US20030049839A1 (en) * | 2001-08-01 | 2003-03-13 | The University Of Texas System | Transparent multi-channel cell scaffold that creates a cellular and/or molecular gradient |
US6716225B2 (en) * | 2001-08-02 | 2004-04-06 | Collagen Matrix, Inc. | Implant devices for nerve repair |
WO2003030836A2 (en) * | 2001-10-12 | 2003-04-17 | Case Western Reserve University | Neuronal regeneration |
US7041506B2 (en) * | 2001-11-19 | 2006-05-09 | Becton Dickinson And Company | Peptides promoting cell adherence, growth and secretion |
AU2002351164A1 (en) * | 2001-11-26 | 2003-06-10 | Molecular Reflections, Inc. | Microscale immobilization of molecules using a hydrogel and methods of use thereof |
US7429267B2 (en) * | 2001-12-04 | 2008-09-30 | The Trustees Of The University Of Pennsylvania | Device and method using integrated neuronal cells and an electronic device |
KR100493461B1 (ko) * | 2002-02-27 | 2005-06-07 | 재단법인서울대학교산학협력재단 | 접착분자가 부착된 천연고분자, 그의 제조방법 및 그의 용도 |
US8298606B2 (en) | 2002-03-08 | 2012-10-30 | The Regents Of The University Of California | Methods and compositions for stabilizing the myocardium |
US6932833B1 (en) * | 2002-04-01 | 2005-08-23 | Bobby W. Presley | Method and barrier for limiting fluid movement through a tissue rent |
US20070100358A2 (en) * | 2002-08-01 | 2007-05-03 | Texas Scottish Rite Hospital For Children | A Biomimetic Synthetic Nerve Implant |
WO2005046457A2 (en) * | 2003-11-05 | 2005-05-26 | Texas Scottish Rite Hospital For Children | A biomimetic biosynthetic nerve implant |
US20060034807A1 (en) * | 2002-08-09 | 2006-02-16 | Ottawa Health Research Institute | Innervated artificial tissues and uses thereof |
JP4571776B2 (ja) * | 2002-11-05 | 2010-10-27 | Jx日鉱日石エネルギー株式会社 | 潤滑油組成物 |
AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
JP4605985B2 (ja) * | 2002-12-27 | 2011-01-05 | ニプロ株式会社 | 神経再生誘導管 |
SI1594436T1 (sl) | 2003-01-31 | 2011-01-31 | Biogen Idec Inc | Mutirani neoblastin |
US20040156878A1 (en) * | 2003-02-11 | 2004-08-12 | Alireza Rezania | Implantable medical device seeded with mammalian cells and methods of treatment |
EP1618179B1 (en) | 2003-04-18 | 2014-05-07 | Biogen Idec MA Inc. | Polymer-conjugated glycosylated neublastin |
WO2005014784A2 (en) * | 2003-06-20 | 2005-02-17 | Tumer Tumay O | System for molecular imaging |
US8545386B2 (en) * | 2003-08-14 | 2013-10-01 | Boston Scientific Scimed, Inc. | Surgical slings |
WO2005020677A1 (en) | 2003-08-29 | 2005-03-10 | The Walter And Eliza Hall Institute Of Medical Research | Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening |
NZ547767A (en) | 2003-12-24 | 2010-05-28 | Inst Medical W & E Hall | Therapeutic agents and uses therefor |
US7709439B2 (en) * | 2004-02-20 | 2010-05-04 | Boston Scientific Scimed, Inc. | Biomaterials for enhanced healing |
US7840263B2 (en) | 2004-02-27 | 2010-11-23 | Cardiac Pacemakers, Inc. | Method and apparatus for device controlled gene expression |
GB0405045D0 (en) * | 2004-03-05 | 2004-04-07 | Spinox Ltd | Composite materials |
US20060134779A1 (en) * | 2004-03-10 | 2006-06-22 | Banes Albert J | Modulation of cell intrinsic strain to control cell modulus, matrix synthesis, secretion, organization, material properties and remodeling of tissue engineered constructs |
WO2005099758A2 (en) * | 2004-04-17 | 2005-10-27 | The Board Of Trustees The Leland Standford Junior University | Injectable bioartificial tissue matrix |
WO2005108981A1 (en) | 2004-05-12 | 2005-11-17 | The Walter And Eliza Hall Institute Of Medical Research | A method of cell isolation |
US7764995B2 (en) | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
EP1778120A4 (en) * | 2004-07-15 | 2009-07-08 | Dentigenix Inc | MINERALIZING COMPOSITE MATERIALS FOR RECONSTITUTION OF TEETH |
CN101043899B (zh) * | 2004-08-19 | 2011-03-30 | 比奥根艾迪克Ma公司 | 重折叠转化型生长因子beta家族蛋白 |
MX2007002029A (es) * | 2004-08-19 | 2007-03-28 | Biogen Idec Inc | Variantes de neublastina. |
DE602005013979D1 (de) * | 2004-09-14 | 2009-05-28 | Neurotex Ltd | Verfahren und gerät für verstärktes wachstum von peripheren nerven und nervengewebe |
US20060079927A1 (en) * | 2004-10-08 | 2006-04-13 | Medtronic Vascular, Inc., A Delaware Corporation | Detachable joint catheter and method |
US7235592B2 (en) | 2004-10-12 | 2007-06-26 | Zimmer Gmbh | PVA hydrogel |
CN102772824A (zh) * | 2004-12-08 | 2012-11-14 | 渗透治疗有限公司 | 增强血管通路的方法和组合物 |
US8060219B2 (en) | 2004-12-20 | 2011-11-15 | Cardiac Pacemakers, Inc. | Epicardial patch including isolated extracellular matrix with pacing electrodes |
US7981065B2 (en) | 2004-12-20 | 2011-07-19 | Cardiac Pacemakers, Inc. | Lead electrode incorporating extracellular matrix |
US8874204B2 (en) | 2004-12-20 | 2014-10-28 | Cardiac Pacemakers, Inc. | Implantable medical devices comprising isolated extracellular matrix |
US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
EP1848470A2 (en) * | 2005-02-17 | 2007-10-31 | Abbott Cardiovascular Systems, Inc. | Coatings for implantable medical devices containing attractants for endothelial cells |
WO2006091706A1 (en) | 2005-02-23 | 2006-08-31 | Zimmer Technology, Inc. | Blend hydrogels and methods of making |
US7851189B2 (en) * | 2005-03-07 | 2010-12-14 | Boston Scientific Scimed, Inc. | Microencapsulated compositions for endoluminal tissue engineering |
DE602006014814D1 (de) * | 2005-04-21 | 2010-07-22 | Massachusetts Inst Technology | Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene, einschliesslich genidentischer und nicht-genidentischer zellen, gewebe oder organe |
EP1901680B1 (en) * | 2005-06-21 | 2015-04-15 | Shire Regenerative Medicine, Inc. | Crypreservation of biocompatible material |
DK2407484T3 (en) | 2005-06-24 | 2016-09-05 | The Walter And Eliza Hall Inst Of Medical Res | Therapeutic pro-apoptotic BH3-like molecules, and methods of generating and / or selecting those |
US20070048383A1 (en) * | 2005-08-25 | 2007-03-01 | Helmus Michael N | Self-assembled endovascular structures |
DE102005040816A1 (de) * | 2005-08-29 | 2007-03-15 | Skh-Gmbh | Leitschiene für die Regeneration von degeneriertem neuronalen Gewebe |
EP1926459B1 (en) | 2005-09-19 | 2015-01-07 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
US20070190165A1 (en) * | 2005-10-21 | 2007-08-16 | Brey Eric M | Tissue-specific basement membrane gels |
US20100204783A1 (en) * | 2005-12-06 | 2010-08-12 | Helen Marie Nugent | Methods and compositions for enhancing vascular access |
EP1957124A2 (en) | 2005-12-07 | 2008-08-20 | Zimmer Inc. | Methods of bonding or modifying hydrogels using irradiation |
US8017107B2 (en) | 2005-12-22 | 2011-09-13 | Zimmer, Inc. | Perfluorocyclobutane crosslinked hydrogels |
TWI501774B (zh) | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
ES2450065T3 (es) * | 2006-03-01 | 2014-03-21 | Biogen Idec Ma Inc. | Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF |
US8110242B2 (en) | 2006-03-24 | 2012-02-07 | Zimmer, Inc. | Methods of preparing hydrogel coatings |
US8092818B2 (en) * | 2006-05-17 | 2012-01-10 | Boston Scientific Scimed, Inc. | Medical devices having bioactive surfaces |
US7625552B2 (en) * | 2006-05-30 | 2009-12-01 | Boston Scientific Scimed, Inc. | Bioactive polymers for imparting bioactive character to hydrophobic medical article surfaces |
WO2007147014A2 (en) * | 2006-06-13 | 2007-12-21 | Fmc Biopolymer As | Method and systems for using biopolymer-based beads and hydrogels |
AU2007275764B2 (en) | 2006-07-18 | 2013-11-14 | University Of Utah Research Foundation | Methods for treating pain and screening analgesic compounds |
JP4569543B2 (ja) * | 2006-08-18 | 2010-10-27 | ニプロ株式会社 | 膨潤可能な棒状体を備えた組織再生器具の前駆体 |
EP2468314A1 (en) * | 2006-09-06 | 2012-06-27 | Boston Scientific Limited | Medical devices having a coating for promoting endothelial cell adhesion |
WO2008063878A2 (en) * | 2006-11-06 | 2008-05-29 | Bonwrx, Inc. | Nerve regeneration device |
WO2008057580A2 (en) * | 2006-11-07 | 2008-05-15 | Pervasis Therapeutics, Inc. | Materials and methods for treating and managing angiogenesis-mediated diseases |
WO2008103744A1 (en) * | 2007-02-20 | 2008-08-28 | Rutgers, The State University Of New Jersey | Nerve guidance tubes |
WO2008112163A1 (en) * | 2007-03-09 | 2008-09-18 | Corning Incorporated | Gum coatings for cell culture, methods of manufacture and methods of use |
US8080418B2 (en) * | 2007-03-09 | 2011-12-20 | Corning Incorporated | Method of making a three dimensional cell culture matrix |
WO2008113005A2 (en) * | 2007-03-15 | 2008-09-18 | Boston Scientific Scimed, Inc. | Methods to improve the stability of cellular adhesive proteins and peptides |
WO2008121331A1 (en) * | 2007-03-30 | 2008-10-09 | Pervasis Therapeutics, Inc. | Materials and methods for treating nerve damage and promoting nerve repair and regeneration |
WO2008122044A2 (en) * | 2007-04-02 | 2008-10-09 | Georgia Tech Research Corporation | Implantable device for communicating with biological tissue |
TWI445544B (zh) * | 2007-05-01 | 2014-07-21 | Biogen Idec Inc | 增進血管形成之組合物及方法 |
ATE545441T1 (de) * | 2007-06-13 | 2012-03-15 | Pervasis Therapeutics Inc | Verfahren und vorrichtungen zur minimal invasiven abgabe von zellhaltigen fliessfähigen zusammensetzungen |
US8685107B2 (en) | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
US20090054984A1 (en) | 2007-08-20 | 2009-02-26 | Histogenics Corporation | Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects |
US7731988B2 (en) | 2007-08-03 | 2010-06-08 | Zimmer, Inc. | Multi-polymer hydrogels |
US20110135648A1 (en) * | 2007-08-08 | 2011-06-09 | Biogen Idec Ma Inc. | Anti-neublastin antibodies and uses thereof |
EP2182887B1 (en) | 2007-08-20 | 2016-12-14 | Histogenics Corporation | A method for improvement of differentiation of mesenchymal stem cells using a double-structured tissue implant |
US8062739B2 (en) | 2007-08-31 | 2011-11-22 | Zimmer, Inc. | Hydrogels with gradient |
ATE537857T1 (de) * | 2007-09-21 | 2012-01-15 | Boston Scient Scimed Inc | Medizinische vorrichtungen mit oberflächen mit nanofaser-struktur |
US20090104244A1 (en) * | 2007-09-21 | 2009-04-23 | Boston Scientific Scimed, Inc. | Therapeutic agent-eluting medical devices having textured polymeric surfaces |
WO2009043052A1 (en) * | 2007-09-27 | 2009-04-02 | Columbia University | Methods and systems for forming biocompatible materials |
US7947784B2 (en) | 2007-11-16 | 2011-05-24 | Zimmer, Inc. | Reactive compounding of hydrogels |
WO2009086535A2 (en) * | 2007-12-27 | 2009-07-09 | The Trustees Of Columbia University In The City Of New York | Systems and methods for forming patterned extracellular matrix materials |
US8034362B2 (en) | 2008-01-04 | 2011-10-11 | Zimmer, Inc. | Chemical composition of hydrogels for use as articulating surfaces |
US8668863B2 (en) * | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
US20090297581A1 (en) * | 2008-05-28 | 2009-12-03 | Boston Scientific Scimed, Inc. | Medical devices having electrodeposited coatings |
WO2009158325A2 (en) * | 2008-06-25 | 2009-12-30 | Boston Scientific Scimed, Inc. | Medical devices having surface coatings |
JP2011526186A (ja) * | 2008-06-26 | 2011-10-06 | ボストン サイエンティフィック サイムド,インコーポレイテッド | 荷電材料を含む医療機器コーティング |
US11090387B2 (en) * | 2008-12-22 | 2021-08-17 | The Trustees Of The University Of Pennsylvania | Hydrolytically degradable polysaccharide hydrogels |
US8574612B2 (en) * | 2009-03-04 | 2013-11-05 | Boston Scientific Scimed, Inc. | Medical devices having a coating of biologic macromolecules |
ES2644599T3 (es) * | 2009-09-02 | 2017-11-29 | Lifecell Corporation | Injertos vasculares procedentes de matrices de tejido acelular |
WO2011041478A1 (en) | 2009-10-02 | 2011-04-07 | Baxter International Inc. | Hematopoietic stem cells for use in the treatment of a kidney injury |
AU2010314994B2 (en) | 2009-11-09 | 2016-10-06 | Spotlight Technology Partners Llc | Fragmented hydrogels |
CN102695500A (zh) | 2009-11-09 | 2012-09-26 | 聚光灯技术合伙有限责任公司 | 多糖基水凝胶 |
KR102173873B1 (ko) | 2009-11-12 | 2020-11-04 | 브이셀 세라퓨틱스 인코포레이티드 | 포자를 닮은 세포들의 계군 및 그 용도 |
WO2011068778A1 (en) * | 2009-12-03 | 2011-06-09 | Lifecell Corporation | Nerve treatment devices and methods |
WO2011151832A1 (en) | 2010-06-03 | 2011-12-08 | Ramot At Tel-Aviv University Ltd. | Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof |
EP2624874A4 (en) | 2010-10-08 | 2014-04-02 | Univ Texas | ADHESIVE MEMBRANE WITH ALGINATE AND HYALURONIC ACID FOR BIOMEDICAL APPLICATIONS |
WO2012048283A1 (en) | 2010-10-08 | 2012-04-12 | Board Of Regents, The University Of Texas System | One-step processing of hydrogels for mechanically robust and chemically desired features |
US9486404B2 (en) | 2011-03-28 | 2016-11-08 | The Trustees Of The University Of Pennsylvania | Infarction treatment compositions and methods |
EP2793966B1 (en) | 2011-12-22 | 2018-03-28 | Centre Hospitalier Universitaire Vaudois (CHUV) | Selective plasma activation for medical implants and wound healing devices |
EP2817014A2 (en) | 2012-02-21 | 2014-12-31 | Baxter International Inc | Pharmaceutical composition comprising cd34+ cells |
CN103542082B (zh) * | 2012-07-16 | 2016-04-27 | 鸿富锦精密工业(深圳)有限公司 | 齿轮传动机构及机械臂连接结构 |
US11565027B2 (en) | 2012-12-11 | 2023-01-31 | Board Of Regents, The University Of Texas System | Hydrogel membrane for adhesion prevention |
TWI686205B (zh) | 2013-05-31 | 2020-03-01 | 美國猶他大學研究基金會 | 芋螺毒素(conotoxin)肽,其醫藥組合物及用途 |
AU2014324459B2 (en) | 2013-09-30 | 2018-10-11 | Bioactive Regenerative Therapeutics, Inc. | Biomimetic hybrid gel compositions and methods of use |
EP3038521B1 (en) * | 2013-10-12 | 2019-05-01 | Innovative Surface Technologies, Inc. | Tissue scaffolds for electrically excitable cells |
US20150141786A1 (en) * | 2013-11-15 | 2015-05-21 | Case Western Reserve University | Interfacing With The Peripheral Nervous System (PNS) Using Targeted Fascicular Interface Device |
CN105979978A (zh) | 2013-12-30 | 2016-09-28 | 波士顿科学国际有限公司 | 功能化的光滑医疗器械涂层 |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
CN108884135B (zh) | 2015-10-27 | 2024-03-26 | 昆士兰大学 | 治疗方法以及可用于其中的药剂 |
AU2017301511B2 (en) | 2016-07-25 | 2023-05-18 | Cerapedics, Inc. | Peptide-coated calcium phosphate particles |
US11150251B2 (en) | 2016-10-07 | 2021-10-19 | Clemson University Research Foundation | Bi-functional arginine-glycine-aspartic acid (RGD) peptides and methods to promote angiogenesis |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4495288A (en) * | 1981-03-13 | 1985-01-22 | Damon Biotech, Inc. | Method of culturing anchorage dependent cells |
US4829000A (en) * | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
US5019087A (en) * | 1986-10-06 | 1991-05-28 | American Biomaterials Corporation | Nerve regeneration conduit |
US5092871A (en) * | 1987-03-13 | 1992-03-03 | Brown University Research Foundation | Electrically-charged nerve guidance channels |
US5030225A (en) * | 1987-03-13 | 1991-07-09 | Brown University Research Foundation | Electrically-charged nerve guidance channels |
FR2616318A1 (fr) * | 1987-06-15 | 1988-12-16 | Centre Nat Rech Scient | Peau artificielle et son procede de preparation |
US5147797A (en) * | 1987-08-25 | 1992-09-15 | Regents Of The University Of Minnesota | Polypeptides with fibronectin activity |
US5171271A (en) * | 1987-08-25 | 1992-12-15 | Regents Of The University Of Minnesota | Polypeptides with fibronectin activity |
US5294551A (en) * | 1987-08-25 | 1994-03-15 | Regents Of The University Of Minnesota | Cell culture substrate coated with polypeptides having fibronectin activity |
US5202120A (en) * | 1987-09-11 | 1993-04-13 | Case Western Reserve University | Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
SE8703625D0 (sv) * | 1987-09-18 | 1987-09-18 | Kabivitrum Ab | New medical use |
US5158881A (en) * | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
US5106627A (en) * | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
US5156844A (en) * | 1987-11-17 | 1992-10-20 | Brown University Research Foundation | Neurological therapy system |
US5283187A (en) * | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
US5250414A (en) * | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
US5011486A (en) * | 1988-11-18 | 1991-04-30 | Brown University Research Foundation | Composite nerve guidance channels |
US5082670A (en) * | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
US5026381A (en) * | 1989-04-20 | 1991-06-25 | Colla-Tec, Incorporated | Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit |
US4963146A (en) * | 1989-04-20 | 1990-10-16 | Colla-Tec Incorporated | Multi-layered, semi-permeable conduit for nerve regeneration |
US5354736A (en) * | 1989-08-14 | 1994-10-11 | Regents Of The University Of California | Synthetic compounds and compositions with enhanced cell binding |
US5330911A (en) * | 1989-09-28 | 1994-07-19 | Board Of Regents, The University Of Texas System | Surfaces having desirable cell adhesive effects |
US5081031A (en) * | 1989-12-14 | 1992-01-14 | Regents Of The University Of Minnesota | Synthetic polypeptide with type iv collagen activity |
US5082926A (en) * | 1989-12-14 | 1992-01-21 | Regents Of The University Of Minnesota | Polypeptide with type iv collagen cell adhesion, spreading and motility activity |
AU8649391A (en) * | 1990-08-15 | 1992-03-17 | University Of Miami | Autotransplantation of schwann cells to promote nervous system repair |
ES2107537T3 (es) * | 1991-04-25 | 1997-12-01 | Univ Brown Res Found | Vehiculo inmunoaislante biocompatible implantable para suministrar productos terapeuticos seleccionados. |
CA2113118C (en) * | 1991-07-08 | 2002-09-17 | Samuel Weiss | Novel growth factor-responsive progenitor cells which can be proliferated in vitro |
WO1993010722A2 (en) * | 1991-11-26 | 1993-06-10 | Research Development Foundation | Fetal membrane tubes for nerve and vessel grafts |
JPH07503467A (ja) * | 1992-01-23 | 1995-04-13 | ニューヨーク ユニヴァーシティー | 細胞を脳に移植する方法及びその治療使用 |
US5279966A (en) * | 1992-04-02 | 1994-01-18 | The Trustees Of Columbia University In The City Of New York | Cloning, expression and uses of a novel secreted protein, F-spondin |
US5834029A (en) * | 1994-07-20 | 1998-11-10 | Cytotherapeutics, Inc. | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment |
-
1994
- 1994-07-20 US US08/280,646 patent/US5834029A/en not_active Expired - Lifetime
-
1995
- 1995-07-19 IL IL11467295A patent/IL114672A/xx active IP Right Grant
- 1995-07-19 ZA ZA956033A patent/ZA956033B/xx unknown
- 1995-07-20 AU AU31423/95A patent/AU3142395A/en not_active Abandoned
- 1995-07-20 WO PCT/US1995/009282 patent/WO1996002286A1/en active IP Right Grant
- 1995-07-20 EP EP95927374A patent/EP0772466B1/en not_active Expired - Lifetime
- 1995-07-20 CA CA002194493A patent/CA2194493A1/en not_active Abandoned
- 1995-07-20 DE DE69532240T patent/DE69532240D1/de not_active Expired - Lifetime
- 1995-07-20 KR KR1019970700282A patent/KR970704481A/ko not_active Application Discontinuation
- 1995-07-20 TR TR95/00883A patent/TR199500883A2/xx unknown
- 1995-07-20 JP JP8505272A patent/JPH10503098A/ja active Pending
- 1995-07-20 AT AT95927374T patent/ATE255425T1/de not_active IP Right Cessation
- 1995-08-20 TR TR95/00884A patent/TR199500884A2/xx unknown
-
1997
- 1997-01-14 NO NO970155A patent/NO970155L/no not_active Application Discontinuation
- 1997-01-17 FI FI970218A patent/FI970218A/fi unknown
-
1998
- 1998-09-25 US US09/160,654 patent/US6156572A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL114672A0 (en) | 1995-11-27 |
NO970155D0 (no) | 1997-01-14 |
NO970155L (no) | 1997-03-19 |
EP0772466A1 (en) | 1997-05-14 |
DE69532240D1 (de) | 2004-01-15 |
EP0772466B1 (en) | 2003-12-03 |
IL114672A (en) | 2000-12-06 |
FI970218A (fi) | 1997-03-17 |
US6156572A (en) | 2000-12-05 |
CA2194493A1 (en) | 1996-02-01 |
JPH10503098A (ja) | 1998-03-24 |
US5834029A (en) | 1998-11-10 |
KR970704481A (ko) | 1997-09-06 |
TR199500883A2 (tr) | 1996-06-21 |
TR199500884A2 (tr) | 1996-06-21 |
FI970218A0 (fi) | 1997-01-17 |
WO1996002286A1 (en) | 1996-02-01 |
ATE255425T1 (de) | 2003-12-15 |
AU3142395A (en) | 1996-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA956033B (en) | Compositions and methods for a bioartificial extracellular matrix | |
Sims et al. | Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes | |
JP4237415B2 (ja) | 可移植性軟骨組織のinvitroでの製造 | |
US5665391A (en) | Cultured, full-thickness integument substitutes based on three-dimensional matrix membranes | |
EP0871414A4 (en) | TREATED TISSUE FOR IMPLANTATION AND MANUFACTURING METHOD | |
US20040101959A1 (en) | Treatment of tissue with undifferentiated mesenchymal cells | |
DE69837491D1 (de) | Menschliche mesenchymale stammzellen aus peripherem blut | |
FI960809A (fi) | Hermoregeneraatio käyttäen ihmisen luun morfogeneettisiä proteiineja | |
CA2213533A1 (en) | Resorbable extracellular matrix for reconstruction of cartilage tissue | |
DE69831964D1 (de) | Zusammensetzung zur förderung des wachstums von duralem oder meningealem gewebe enthaltend kollagen | |
ES2196317T3 (es) | Canal neural artificial. | |
GB9400163D0 (en) | Membrane | |
DE69637730D1 (de) | Verfahren zur in vito vorbehandlung von myoblasten vor deren transplantation | |
NO20052949L (no) | Implantat inneholdende dyrkede bruksceller og fremgangsmate for fremstilling | |
AU2002364664B2 (en) | Device for active phase cell or tissue sampling and uses thereof | |
Takahashi et al. | Autogenous callo-osseous grafts for the repair of osteochondral defects | |
WO1992003536A1 (en) | Autotransplantation of schwann cells to promote nervous system repair | |
WO1996003160A1 (en) | Fibrin-cell suspension for construction of new tissue | |
BR9604371B8 (pt) | biomembrana adequada para uso na substituição, reconstrução, indução de angiogênese, neoformação ou regeneração de tecidos ou órgãos humanos e animais, material substituto, uso da biomembrana e suporte para o crescimento de microorganismos e células. | |
US20220062505A1 (en) | Nerve grafts and methods of preparation thereof | |
JP2007502127A (ja) | 生体外で軟骨様組織を生成させる方法 | |
US6429193B1 (en) | Cell chemotactic factor (cctf) originating in mammalian tooth pricement or cement, method for purifying the same, and novel connective tissue adhesion promoters containing the same as the active ingredient | |
TW202227105A (zh) | 神經移植物及其製備方法 | |
CA2215200C (en) | Biodegradable device | |
UA19495A (uk) | Спосіб пластики післяопераційhих кісткових порожhиh щелеп |